Impact of Polypharmacy for Chronic Ailments in Colon Cancer Patients: A Review Focused on Drug Repurposing
Colorectal cancer is characterized by high incidence worldwide. Despite increased awareness and early diagnosis thanks to screening programmes, mortality remains high, particularly for patients with metastatic involvement. Immune checkpoint inhibitors or poly (ADP-ribose) polymerase (PARP)-inhibitor...
Main Authors: | Riccardo Giampieri, Luca Cantini, Enrica Giglio, Alessandro Bittoni, Andrea Lanese, Sonia Crocetti, Federica Pecci, Cecilia Copparoni, Tania Meletani, Edoardo Lenci, Alessio Lupi, Maria Giuditta Baleani, Rossana Berardi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-09-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/10/2724 |
Similar Items
-
The Prospect of Repurposing Immunomodulatory Drugs for Adjunctive Chemotherapy against Tuberculosis: A Critical Review
by: Chiyun Lee, et al.
Published: (2021-01-01) -
Unlocking the Medicinal Mysteries: Preventing Lacunar Stroke with Drug Repurposing
by: Linjing Zhang, et al.
Published: (2023-12-01) -
Retrospective Comparative Analysis of KRAS G12C vs. Other KRAS Mutations in mCRC Patients Treated With First-Line Chemotherapy Doublet + Bevacizumab
by: Riccardo Giampieri, et al.
Published: (2021-09-01) -
NSAIDs as a Drug Repurposing Strategy for Biofilm Control
by: Cláudia Leão, et al.
Published: (2020-09-01) -
Repurposing of FDA-Approved NSAIDs for DPP-4 Inhibition as an Alternative for Diabetes Mellitus Treatment: Computational and in Vitro Study
by: Veera C. S. R. Chittepu, et al.
Published: (2019-05-01)